Hang Junjie, Wei Feifei, Yan Zhiying, Zhang Xianming, Xu Kequn, Zhu Yingwei
Department of Oncology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu, 213003, People's Republic of China.
Open Med (Wars). 2021 May 15;16(1):795-804. doi: 10.1515/med-2021-0251. eCollection 2021.
Colon cancer is one of the malignant tumors that threatens human health. miR-510 was demonstrated to play roles in the progression of various cancers; its dysregulation was speculated to be associated with the development of colon cancer.
One hundred and thirteen colon cancer patients participated in this research. With the help of RT-qPCR, the expression of miR-510 in collected tissues and cultured cells was analyzed. The association between miR-510 expression level and clinical features and prognosis of patients was evaluated. Moreover, the effects of miR-510 on cell proliferation, migration, and invasion of colon cancer were assessed by CCK8 and Transwell assay.
miR-510 significantly upregulated in colon cancer tissues and cell lines relative to the adjacent normal tissues and colonic cells. The expression of miR-510 was significantly associated with the TNM stage and poor prognosis of patients, indicating miR-510 was involved in the disease progression and clinical prognosis of colon cancer. Additionally, the upregulation of miR-510 significantly promoted cell proliferation, migration, and invasion of colon cancer, while its knockdown significantly inhibited these cellular processes. SRCIN 1 was the direct target of miR-510 during its promoted effect on the development of colon cancer.
The upregulation of miR-510 acts as an independent prognostic indicator and a tumor promoter by targeting SRCIN 1 in colon cancer, which provides novel therapeutic strategies for colon cancer.
结肠癌是威胁人类健康的恶性肿瘤之一。已证明miR-510在多种癌症进展中发挥作用;推测其失调与结肠癌的发生发展有关。
113例结肠癌患者参与本研究。借助RT-qPCR分析收集组织和培养细胞中miR-510的表达。评估miR-510表达水平与患者临床特征及预后的相关性。此外,通过CCK8和Transwell实验评估miR-510对结肠癌细胞增殖、迁移和侵袭的影响。
与相邻正常组织和结肠细胞相比,miR-510在结肠癌组织和细胞系中显著上调。miR-510的表达与患者的TNM分期及不良预后显著相关,表明miR-510参与了结肠癌的疾病进展和临床预后。此外,miR-510的上调显著促进结肠癌细胞的增殖、迁移和侵袭,而其敲低则显著抑制这些细胞过程。SRCIN 1是miR-510在促进结肠癌发展过程中的直接靶点。
miR-510的上调通过靶向结肠癌中的SRCIN 1作为独立的预后指标和肿瘤促进因子,为结肠癌提供了新的治疗策略。